Disruptions in Availability of Neurosurgical Patties, Sponges, and Strips - Letter to Health Care Providers
The FDA issued a Letter to Health Care Providers regarding a supply disruption for Neurosurgical Patties, Sponges, and Strips identified by product code HBA.
This affects neurosurgical departments, surgical staff, healthcare procurement professionals, and manufacturers of neurosurgical patties, sponges, and strips under product code HBA.
A disruption in these essential surgical materials may require facilities to reassess surgical schedules or seek alternative supplies to maintain standard of care in neurosurgical procedures. The FDA notification suggests that the shortage is significant enough to warrant formal communication to the clinical community, potentially indicating a widespread impact across the product class.
Clinical and procurement teams should evaluate current inventory levels of HBA-coded neurosurgical materials. Regulatory and supply chain departments should monitor for further FDA updates regarding the duration of the disruption and potential alternative suppliers or products.
The FDA issued a LHCP to notify providers that Neurosurgical Patties, Sponges, and Strips (product code HBA) are experiencing a supply disruption.
Open in openFDA / FDA.gov